References
Lazarou J, Pomeranz BH, Corey PN (1998) Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. Jama 279: 1200–1205
Pirmohamed M, James S, Meakin S, et al (2004) Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients. Bmj 329: 15–19
Davies EC, Green CF, Taylor S, Williamson PR, Mottram DR, Pirmohamed M (2009) Adverse drug reactions in hospital in-patients: a prospective analysis of 3695 patient-episodes. PLoS One 4: e4439
Budnitz DS, Pollock DA, Weidenbach KN, Mendelsohn AB, Schroeder TJ, Annest JL (2006) National surveillance of emergency department visits for outpatient adverse drug events. JAMA 296: 1858–1866
Gandhi TK, Weingart SN, Borus J, et al (2003) Adverse drug events in ambulatory care. N Engl J Med 348: 1556–1564
Moore TJ, Cohen MR, Furberg CD (2007) Serious adverse drug events reported to the Food and Drug Administration, 1998–2005. Arch Intern Med 167: 1752–1759
Ferner RE, Aronson JK (2010) EIDOS: a mechanistic classification of adverse drug effects. Drug Saf 33: 15–23
Aronson JK, Ferner RE (2003) Joining the DoTS: new approach to classifying adverse drug reactions. BMJ 327: 1222–1225
Agrawal A, Aronson JK, Britten N, et al (2009) Medication errors: problems and recommendations from a consensus meeting. Br J Clin Pharmacol 67: 592–598
Fokter N, Mozina M, Brvar M (2010) Potential drug-drug interactions and admissions due to drug-drug interactions in patients treated in medical departments. Wien Klin Wochenschr 122: 81–88
Spencer FA, Lessard D, Yarzebski J, Gore JM, Goldberg RJ (2005) Decade-long changes in the use of combination evidence-based medical therapy at discharge for patients surviving acute myocardial infarction. Am Heart J 150: 838–844
Floyd KC, Yarzebski J, Spencer FA, et al (2009) A 30-year perspective (1975–2005) into the changing landscape of patients hospitalized with initial acute myocardial infarction: Worcester Heart Attack Study. Circ Cardiovasc Qual Outcomes 2: 88–95
McKinnon JE, Mellors JW, Swindells S (2009) Simplification strategies to reduce antiretroviral drug exposure: progress and prospects. Antivir Ther 14: 1–12
Egger SS, Ratz Bravo AE, Hess L, Schlienger RG, Krahenbuhl S (2007) Age-related differences in the prevalence of potential drug-drug interactions in ambulatory dyslipidaemic patients treated with statins. Drugs Aging 24: 429–440
Davies EC, Green CF, Mottram DR, Pirmohamed M (2007) Adverse drug reactions in hospitals: a narrative review. Curr Drug Saf 2: 79–87
Pitt B, Zannad F, Remme WJ, et al (1999) The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. N Engl J Med 341: 709–717
Juurlink DN, Mamdani MM, Lee DS, et al (2004) Rates of hyperkalemia after publication of the Randomized Aldactone Evaluation Study. N Engl J Med 351: 543–551
McMurray JJ, O'Meara E (2004) Treatment of heart failure with spironolactone – trial and tribulations. N Engl J Med 351: 526–528
Lau HS, Florax C, Porsius AJ, De Boer A (2000) The completeness of medication histories in hospital medical records of patients admitted to general internal medicine wards. Br J Clin Pharmacol 49: 597–603
Kaushal R, Shojania KG, Bates DW (2003) Effects of computerized physician order entry and clinical decision support systems on medication safety: a systematic review. Arch Intern Med 163: 1409–1416
Constable S, Ham A, Pirmohamed M (2007) Herbal medicines and acute medical emergency admissions to hospital. Br J Clin Pharmaco. 63: 247–248
Bellosta S, Paoletti R, Corsini A (2004) Safety of statins: focus on clinical pharmacokinetics and drug interactions. Circulation 109: III50–III57
Seidling HM, Storch CH, Bertsche T, et al (2009) Successful strategy to improve the specificity of electronic statin-drug interaction alerts. Eur J Clin Pharmacol 65: 1149–1157
Pirmohamed M, Ferner RE (2003) Monitoring drug treatment – criteria used for screening tests should apply to monitoring. Br Med J 327: 1179–1181
Norgard NB, Mathews KD, Wall GC (2009) Drug-drug interaction between clopidogrel and the proton pump inhibitors. Ann Pharmacother 43: 1266–1274
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Pirmohamed, M. Drug-drug interactions and adverse drug reactions: separating the wheat from the chaff. Wien Klin Wochenschr 122, 62–64 (2010). https://doi.org/10.1007/s00508-010-1309-1
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00508-010-1309-1